(Q39427944)
Statements
1 reference
Substrate specificity of antinuclear antibodies in scleroderma (English)
2 references
Jablonska S
1 reference
T. P. Chorzelski
E. H. Beutner
Jarzabek-Chorzelska M
1 reference
M. Blaszczyk
T. Rogozinski
G. Rzesa
M. Jarzabek-Chorzelska
1 April 1977
1 reference
1 reference
68
1 reference
4
1 reference
191-193
1 reference
124
816
Studies on antinuclear antibodies (English)
Seligmann
1965
282
1174
Antinuclear antibodies. Their frequency and diagnostic association (English)
Ritchie
1970
1
933
A clinical study of serum antinuclear factor (English)
Weir
1961
46
111
Antinuclear antibodies. Their significance in scleroderma (English)
Jordon
1971
11
607
Serum antinuclear anti-bodies in progressive systemic sclerosis (scleroderma) (English)
Rothfield
1968
161
536
Das Verhalten der antinukleären Faktoren bei der Sklerodermie (English)
Barthelmes
1975
177
361
Field tirals by ten laboratories on six commercial conjugates prepared from antisera to human IgG (English)
Beutner
1971
177
327
Antinuclear factor serum (homogeneous). An international collaborative study of the proposed research standard 66/233 (English)
Anderson
1971
27
225
Granulocyte-specific antinuclear factors in serum and synovial fluid in rheumatoid arthritis (English)
Elling
1968
177
309
Antinudear factors (ANF) as determined by the immunofluorescent antibody technique (English)
Faber
1965
12
165
Immunologic and clinical observations of granulocytospecific antinuclear antibodies (English)
Svec
1969
Identifiers
1 reference
1 reference